The lipodystrophy syndrome as a risk marker for cardiovascular disease in patients with HIV/AIDS treated with HAART

Registro completo de metadados
MetadadosDescriçãoIdioma
Autor(es): dc.contributorUniversidade Estadual Paulista (UNESP)-
Autor(es): dc.creatorPereira, Valdelias Xavier-
Autor(es): dc.creatorDe Abreu, Luiz Carlos-
Autor(es): dc.creatorValenti, Vitor E.-
Autor(es): dc.creatorRaimundo, Rodrigo D.-
Autor(es): dc.creatorDa Silva, Mariliza Henrique-
Autor(es): dc.creatorOliveira, Fernando R.-
Autor(es): dc.creatorSalatini, Renata-
Autor(es): dc.creatorRoque, Adriano L.-
Autor(es): dc.creatorDe Toledo Blake, Marcia-
Autor(es): dc.creatorDias, Erick Silva-
Autor(es): dc.creatorFilho, Celso F.-
Autor(es): dc.creatorFinotti, Vivian-
Autor(es): dc.creatorFerreira, Celso-
Data de aceite: dc.date.accessioned2021-03-11T00:37:45Z-
Data de disponibilização: dc.date.available2021-03-11T00:37:45Z-
Data de envio: dc.date.issued2018-12-11-
Data de envio: dc.date.issued2018-12-11-
Data de envio: dc.date.issued2015-01-01-
Fonte completa do material: dc.identifierhttp://dx.doi.org/10.3823/1677-
Fonte completa do material: dc.identifierhttp://hdl.handle.net/11449/171849-
Fonte: dc.identifier.urihttp://educapes.capes.gov.br/handle/11449/171849-
Descrição: dc.descriptionIntroduction: The classic risk factors for cardiovascular disease in healthy individuals are well known, however, it lacks in the literature the mechanisms that predicts cardiovascular disease in the population living with HIV-AIDS treated with HAART and presenting syndrome lipodystrophy. We aimed to investigate the risk of cardiovascular disease in HIV-AIDS patients treated with HAART and lipodystrophy syndrome. Methods: A search was performed in Medline, SciELO, Lilacs and Cochrane using the intersection between the keywords: cardiovascular disease, HIV, AIDS, HAART and lipodystrophy syndrome. Results: The selected studies demonstrated that metabolic disorders such as hyperlipidemia, central adipose hypertrophy and peripheral lipoatrophy, besides the metabolic syndrome and lipodystrophy are maker clear risks of developing cardiovascular disease in these individuals. Conclusion: The metabolic alterations in HIV-AIDS treated with HAART and presenting lipodystrophy syndrome may potentiate the development of cardiovascular diseases.-
Idioma: dc.languageen-
Relação: dc.relationInternational Archives of Medicine-
Relação: dc.relation0,237-
Direitos: dc.rightsopenAccess-
Palavras-chave: dc.subjectAIDS-
Palavras-chave: dc.subjectCardiovascular disease-
Palavras-chave: dc.subjectHIV-
Palavras-chave: dc.subjectLipodystrophy syndrome-
Título: dc.titleThe lipodystrophy syndrome as a risk marker for cardiovascular disease in patients with HIV/AIDS treated with HAART-
Tipo de arquivo: dc.typelivro digital-
Aparece nas coleções:Repositório Institucional - Unesp

Não existem arquivos associados a este item.